Lifestyle intervention for patients with depression in general practice
Official title: Lifestyle InterVEntion Study in General Practice: LIVES - GP
Run by University Medical Center Groningen · NCT06286345 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new lifestyle program designed to help people with depression improve their mental health and overall well-being in a regular doctor's office.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Medical Center Groningen Academic / other |
| Locations | 1 site (Groningen) |
| Trial ID | NCT06286345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with depressive symptoms or disorder, with a body mass index of 25 or higher.
✕Probably not a fit
Patients currently receiving treatment in mental health care or those with severe somatic or neurological diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research investigates the feasibility of a multimodal lifestyle intervention (MLI) tailored for patients with depression in a general practice setting. The study aims to address the unhealthy lifestyle often associated with depression, which can lead to chronic physical diseases like cardiovascular issues. By conducting an observational single-group prospective cohort study with 50 participants, the researchers will evaluate various outcome measures including mental health, lifestyle factors, and quality of life. The goal is to identify key factors that influence the successful implementation of this intervention in primary care.
Why it matters
Potential benefit: If successful, this intervention could improve the overall health and quality of life for patients suffering from depression.
How similar studies have gone: Previous studies have shown promising results for lifestyle interventions in mental health care, but this approach in a general practice setting is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of depressive symptoms or depressive disorder in the past year as registered in the general practice electronic health record and coded according to the International Classification of Primary Care (ICPC) as P03 and P76, respectively, or currently treated for depressive symptoms or depressive disorder in general practice. * At least mild depressive symptom level according to the Quick Inventory Depressive Symptomatology-Self-Report (QIDS-SR) (score ≥6) * Body mass index ≥ 25 kg/m2 or increased waist circumference (\>88 cm (women) of \>102 cm (men)). Exclusion Criteria: * Current treatment in mental health care (GGZ in Dutch) * Severe somatic / neurological disease at the discretion of the GP * Currently participating in another lifestyle intervention * Insufficient proficiency in Dutch * Inability to read and write
Where it's running
-
University Medical Center Groningen
Groningen, Netherlands Recruiting
Study contacts
- Study coordinator: Huibert Burger, MD PhD
- Email: h.burger@umcg.nl
- Phone: +31(0)50 361 6722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.